First Time Loading...

Neurobo Pharmaceuticals Inc
NASDAQ:NRBO

Watchlist Manager
Neurobo Pharmaceuticals Inc Logo
Neurobo Pharmaceuticals Inc
NASDAQ:NRBO
Watchlist
Price: 3.68 USD 13.23% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

NRBO Price Targets Summary
Neurobo Pharmaceuticals Inc

There are no price targets for NRBO.
NRBO Lowest Forecast
Wall Street Target
Not Available
NRBO Average Forecast
Wall Street Target
Not Available
NRBO Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Neurobo Pharmaceuticals Inc Competitors:
Price Targets
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
COX
Nicox SA
401% Upside
ABOS
Acumen Pharmaceuticals Inc
291% Upside
G
GNFT
Genfit SA
198% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
COX
Nicox SA
401% Upside
ABOS
Acumen Pharmaceuticals Inc
291% Upside
G
GNFT
Genfit SA
198% Upside
C
688276
Changchun BCHT Biotechnology Co
62% Upside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside
S
SVE
Synthaverse SA
39% Upside
ZEAL
Zealand Pharma A/S
31% Upside

Revenue
Forecast

Revenue Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Neurobo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
What are analyst estimates?

See Also

Summary
NRBO intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRBO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRBO stock valuation using valuation multiples.
Wall Street Estimates
NRBO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRBO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NRBO's stock price target?
Not Available

NRBO doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.